Featured Research

from universities, journals, and other organizations

Cholesterol-lowering Drugs Shown To Decrease Predictor Of Alzheimer's Disease

Date:
April 22, 2003
Source:
University Of Texas Southwestern Medical Center At Dallas
Summary:
Cholesterol-lowering medications known as statins also play an important role in reducing levels of a strong predictor of Alzheimer's disease, according to a new study from UT Southwestern Medical Center at Dallas researchers.

DALLAS – April 21, 2003 – Cholesterol-lowering medications known as statins also play an important role in reducing levels of a strong predictor of Alzheimer's disease, according to a new study from UT Southwestern Medical Center at Dallas researchers.

Related Articles


In today's issue of the Archives of Neurology, UT Southwestern researchers report that participants who took statins lowered their brain cholesterol levels by 21.4 percent. Brain cholesterol is involved in the formation of amyloid plaques, one of the hallmarks of Alzheimer's disease. Amyloid plaques are waxy buildups that harm brain cells.

"This class of drugs may be potentially beneficial in the treatment of Alzheimer's disease," said Dr. Gloria Vega, professor of clinical nutrition and the study's lead author.

"If we limit cholesterol synthesis in the brain, we may be able to decrease the production of amyloid plaques. The findings from this research provide information about the safety and efficacy of a reasonable dose of a statin on the reduction of brain cholesterol."

There is currently no cure for Alzheimer's disease, which affects four million Americans. But this study, UT Southwestern researchers said, suggests that reducing cholesterol in the brain also can reduce plaque formation, thereby potentially reducing the severity of Alzheimer's disease.

"We've shown that you can take people with Alzheimer's disease, with normal cholesterol levels, and reduce the amount of cholesterol that their brain produces without any adverse side effects," said Dr. Myron Weiner, vice chairman of clinical services in psychiatry and a co-author of the study. The study included 44 Alzheimer's patients, none with cardiovascular disease. The study participants were randomly assigned to receive either 40 milligrams per day of lovastatin, simvastatin or pravastatin, or one gram per day of extended-release niacin (another cholesterol-lowering medication) for a six-week period.

Unlike dietary cholesterol, which is transported to the liver and excreted through the bile, the brain gets rid of cholesterol by first converting it into 24S-hydroxycholesterol, which is elevated in individuals with Alzheimer's disease. The researchers measured, through blood samples, the amount of 24S-hydroxycholesterol to determine how much cholesterol was expelled from the brain.

All three statins reduced levels of 24S-hydroxycholesterol by at least 20 percent, while 24S-hydroxycholesterol levels dropped by 10 percent with extended-release niacin.

"It would be interesting to determine whether a combination of a statin and extended-release niacin has an additive effect on levels of 24S-hydroxycholesterol," said Vega.

Weiner is the lead study investigator at UT Southwestern for the Alzheimer's Disease Cooperative Study, a National Institute on Aging multicenter study, which is evaluating whether statins play a role in slowing the progression of Alzheimer's. Results from that study are expected in the next two years.

"Now that we've shown that statins safely and effectively reduce levels of brain cholesterol, we are studying what statins do cognitively for people with Alzheimer's," he said.

Other researchers involved in the study included Dr. Anne Lipton, assistant professor of neurology and psychiatry; Carol Moore, research assistant in psychiatry; Doris Svetlik, a nurse administrator in psychiatry; and researchers with the Department of Clinical Pharmacology at the University of Bonn Medical Center in Germany.

The study was funded in part by the Wallace, Barbara and Kelly King Charitable Foundation Trust, the Merit Review Grant of the Dallas Veterans Affairs Medical Center, the Moss Heart Foundation and the National Institute on Aging.


Story Source:

The above story is based on materials provided by University Of Texas Southwestern Medical Center At Dallas. Note: Materials may be edited for content and length.


Cite This Page:

University Of Texas Southwestern Medical Center At Dallas. "Cholesterol-lowering Drugs Shown To Decrease Predictor Of Alzheimer's Disease." ScienceDaily. ScienceDaily, 22 April 2003. <www.sciencedaily.com/releases/2003/04/030422075427.htm>.
University Of Texas Southwestern Medical Center At Dallas. (2003, April 22). Cholesterol-lowering Drugs Shown To Decrease Predictor Of Alzheimer's Disease. ScienceDaily. Retrieved November 23, 2014 from www.sciencedaily.com/releases/2003/04/030422075427.htm
University Of Texas Southwestern Medical Center At Dallas. "Cholesterol-lowering Drugs Shown To Decrease Predictor Of Alzheimer's Disease." ScienceDaily. www.sciencedaily.com/releases/2003/04/030422075427.htm (accessed November 23, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, November 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

AFP (Nov. 23, 2014) The arable district of Kenema in Sierra Leone -- at the centre of the Ebola outbreak in May -- has been under quarantine for three months as the cocoa harvest comes in. Duration: 01:32 Video provided by AFP
Powered by NewsLook.com
Don't Fall For Flu Shot Myths

Don't Fall For Flu Shot Myths

Newsy (Nov. 23, 2014) Misconceptions abound when it comes to your annual flu shot. Medical experts say most people older than 6 months should get the shot. Video provided by Newsy
Powered by NewsLook.com
WFP: Ebola Risks Heightened Among Women Throughout Africa

WFP: Ebola Risks Heightened Among Women Throughout Africa

AFP (Nov. 21, 2014) Having children has always been a frightening prospect in Sierra Leone, the world's most dangerous place to give birth, but Ebola has presented an alarming new threat for expectant mothers. Duration: 00:37 Video provided by AFP
Powered by NewsLook.com
Could Your Genes Be The Reason You're Single?

Could Your Genes Be The Reason You're Single?

Newsy (Nov. 21, 2014) Researchers in Beijing discovered a gene called 5-HTA1, and carriers are reportedly 20 percent more likely to be single. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins